Study guide

4.2 Short-Term Tactical Decision Scenarios

CPA Program — Strategic Management Accounting Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Role of Strategic Management Accounting & Value Creation

1.1 Evolution & Role of the Strategic Management Accountant 1.2 Defining & Creating Multi-Stakeholder Value 1.3 The Strategic Management Process & Strategy Formation

2 Chapter 2: Strategic Analysis, Environmental Scanning & Professional Ethics

2.1 External Environmental Scanning: PESTEL & Porter's Five Forces 2.2 Internal Capability Analysis, VRIO & Core Competencies 2.3 Professional Ethics, Governance & Risk in Strategic Management Accounting

3 Chapter 3: Information Architecture, Systems & Behavioral Biases

3.1 Data, Information & Knowledge Architecture 3.2 Management Information Systems, ERP & Digital Technologies 3.3 Decision-Making Needs & Cognitive Biases 3.4 Stakeholder Communication, Sources & Information Integration 3.5 Assessing Information-System Deficiencies & Replacement Needs 3.6 Evaluating, Implementing & Reviewing Information Solutions

4 Chapter 4: Relevant Information, Tactical Decisions & Limiting Factors

4.1 Relevant Cost Analysis & Differential Decision-Making 4.2 Short-Term Tactical Decision Scenarios 4.3 Limiting Factors, Theory of Constraints & Throughput Accounting

5 Chapter 5: Strategic Planning, Master Budgets & Budgetary Control

5.1 Master Budget Architecture & Process 5.2 Financial Budgets & Cash Flow Forecasting 5.3 Budgetary Control & Flexible Budgeting 5.4 Service, Not-for-Profit & Departmental Budgets

6 Chapter 6: Modern Budgeting Methodologies & Behavioral Dynamics

6.1 Alternative Budgeting Systems: ZBB, ABB & Rolling Budgets 6.2 Beyond Budgeting Principles & Dynamic Forecasting 6.3 Behavioral Dimensions of Budgeting

7 Chapter 7: Standard Costing & Comprehensive Variance Analysis

7.1 Standard Cost Setting & Direct Cost Variances 7.2 Overhead Variance Analysis 7.3 Sales Variances: Price, Volume, Mix & Quantity 7.4 Planning vs Operational Variances & Variance Investigation

8 Chapter 8: Project Selection, Governance & Financial Appraisal

8.1 Project Fundamentals, Governance & Life Cycle 8.2 Project Selection & Strategic Alignment 8.3 Capital Investment Appraisal Techniques 8.4 Project Structures, Teams, Supplier Contracts & Probity

9 Chapter 9: Project Scheduling, Earned Value Management & Risk

9.1 Project Scheduling, Network Analysis & Resource Management 9.2 Earned Value Management (EVM) & Project Control 9.3 Project Risk Management, Methodologies & Post-Completion Review 9.4 Completion Decisions, Acceptance, Financial Closure & Knowledge

10 Chapter 10: Performance Management Systems & Responsibility Centers

10.1 Management Control Systems & Simons' Levers of Control 10.2 Responsibility Accounting & Organizational Design 10.3 Designing Effective Key Performance Indicators (KPIs)

11 Chapter 11: Divisional Financial Performance & Transfer Pricing

11.1 Return on Investment (ROI) & Residual Income (RI) 11.2 Economic Value Added (EVA) 11.3 Transfer Pricing in Decentralized Organizations

12 Chapter 12: Strategic Performance Frameworks & Executive Incentives

12.1 The Balanced Scorecard Framework 12.2 Strategy Maps & Causal Linkages 12.3 Multidimensional Performance Frameworks 12.4 Executive Compensation, Incentive Systems & Agency Theory

13 Chapter 13: Strategic Cost Management, Value Chains & Activity-Based Costing

13.1 Strategic Cost Management & Value Chain Analysis 13.2 Activity-Based Costing (ABC) Mechanics 13.3 Activity-Based Management (ABM) & Time-Driven ABC

14 Chapter 14: Strategic Pricing, Target Costing & Life-Cycle Costing

14.1 Strategic Pricing Decisions & Policies 14.2 Target Costing & Kaizen Costing 14.3 Life-Cycle Costing & Environmental Management Accounting

15 Chapter 15: Customer Profitability, Lean Supply Chains & Quality Costs

15.1 Customer Profitability Analysis & Cost-to-Serve 15.2 Supply Chain Management & Lean Operations 15.3 Cost of Quality (COQ) Framework & Total Quality Management 15.4 Outsourcing, Offshoring & Downsizing Decisions

4.2 Short-Term Tactical Decision Scenarios

Key Takeaways Explain This Topic AI

Make-or-buy (outsourcing) appraisals contrast incremental internal production expenses (direct inputs and avoidable fixed costs) against external supplier purchase prices, incorporating facility opportunity costs.

Special pricing decisions under spare capacity evaluate whether incremental revenue exceeds incremental variable and direct fixed costs, while assessing risks of customer backlash and price cannibalization.

Segment or product line discontinuation decisions must compare lost contribution margin against avoidable fixed overheads; allocating unavoidable corporate expenses creates an overhead death spiral.

Qualitative strategic criteria—including supplier reliability, product quality consistency, intellectual property security, and workforce morale—frequently outweigh immediate marginal cost calculations.

Interdependencies among complementary product lines require holistic evaluation, as dropping an apparent loss-making product can undermine sales across high-margin companion lines.

Last updated: October 2026

4.2 Short-Term Tactical Decision Scenarios

Short-term tactical decisions typically involve operational horizons of less than twelve months, during which plant capacity, core technology, and capital commitments remain largely fixed. Strategic management accountants apply relevant cost analysis across three frequent commercial dilemmas:

Make-or-Buy (Outsourcing) Decisions: Determining whether a component or sub-assembly should be manufactured in-house or procured from an external specialist.

Special Pricing Orders: Evaluating whether to accept a non-routine, discounted customer order during periods of excess or idle manufacturing capacity.

Product Line or Segment Discontinuation: Deciding whether to drop an apparently unprofitable division, department, or product line.

1. Make-or-Buy (Outsourcing) Decisions

In a make-or-buy decision, the financial objective is to minimize total relevant costs over the operating cycle.

The Incremental Cost Rule

An internal manufacturing process should only be abandoned in favor of external procurement if the external purchase price is strictly lower than the avoidable in-house costs plus any opportunity benefits realized by repurposing factory space: Avoidable In-House Costs = Direct Materials + Direct Labour + Variable Overheads + Avoidable Fixed Overheads \text{Avoidable In-House Costs} = \text{Direct Materials} + \text{Direct Labour} + \text{Variable Overheads} + \text{Avoidable Fixed Overheads} Avoidable In-House Costs = Direct Materials + Direct Labour + Variable Overheads + Avoidable Fixed Overheads Relevant Make Cost = Avoidable In-House Costs + Opportunity Cost of Freed Capacity \text{Relevant Make Cost} = \text{Avoidable In-House Costs} + \text{Opportunity Cost of Freed Capacity} Relevant Make Cost = Avoidable In-House Costs + Opportunity Cost of Freed Capacity Relevant Buy Cost = External Supplier Purchase Price + Incremental Handling / Inspection Costs \text{Relevant Buy Cost} = \text{External Supplier Purchase Price} + \text{Incremental Handling / Inspection Costs} Relevant Buy Cost = External Supplier Purchase Price + Incremental Handling / Inspection Costs

Unavoidable fixed costs (such as factory building insurance, central site security, and corporate administration) will persist regardless of whether the component is made or bought. Including unavoidable fixed costs in the "Make" column artificially inflates internal production cost and produces flawed outsourcing decisions.

Qualitative and Strategic Risks in Outsourcing

Financial savings can quickly evaporate if operational vulnerabilities emerge:

Supplier Price Gouging: Once internal tooling is dismantled and technical skills are lost, the external supplier possesses switching-cost leverage and may sharply raise prices.

Quality Degradation: Substandard supplier components can damage brand reputation and trigger warranty claims.

Supply Chain Lead-Time Volatility: Geopolitical disruption, freight bottlenecks, or supplier insolvency can halt downstream assembly lines.

Intellectual Property (IP) Theft: Sharing proprietary technical drawings with third-party suppliers risks reverse-engineering and competitive leakage.

2. Special Pricing Orders

Enterprises often receive inquiries from international buyers, private-label distributors, or government agencies seeking bulk discounts below prevailing retail list prices.

The Acceptance Rule Under Idle Capacity

When an enterprise possesses idle or unutilized production capacity that cannot be deployed for standard commercial sales, fixed factory costs are already committed and will be incurred in full. Consequently, a special order is financially advantageous whenever the special bid price exceeds incremental variable and direct project-specific costs: Minimum Acceptable Bid Price = Incremental Variable Cost per Unit + Specific Incremental Fixed Costs Special Order Units + Opportunity Cost per Unit \text{Minimum Acceptable Bid Price} = \text{Incremental Variable Cost per Unit} + \frac{\text{Specific Incremental Fixed Costs}}{\text{Special Order Units}} + \text{Opportunity Cost per Unit} Minimum Acceptable Bid Price = Incremental Variable Cost per Unit + Special Order Units Specific Incremental Fixed Costs ​ + Opportunity Cost per Unit Incremental Contribution = Special Order Revenue − Incremental Costs > 0 \text{Incremental Contribution} = \text{Special Order Revenue} - \text{Incremental Costs} > 0 Incremental Contribution = Special Order Revenue − Incremental Costs > 0

Strategic and Commercial Caveats

Accepting special orders below full absorption cost carries substantial strategic risks:

Market Cannibalization: If the discounted buyer resells the goods into the firm's primary geographical territory, regular full-price customers will migrate to the discounted channel.

Customer Price Retaliation: Existing clients paying regular list prices may demand parity or cancel long-term contracts if discounted pricing becomes public.

Precedent Setting: Customers may refuse to return to standard commercial pricing once baseline price expectations have been anchored downward.

3. Product Line or Segment Discontinuation: The Death Spiral

A pervasive error in management accounting occurs when executive teams examine full absorption income statements and eliminate product lines or business units that report net operating losses.

The Allocated Overhead Death Spiral

When an operating division is closed, its sales revenue and variable costs disappear, alongside any direct avoidable fixed costs (e.g., dedicated plant leases or localized advertising). However, unavoidable allocated common corporate overheads do not vanish . Instead, the accounting department reallocates these fixed overheads across the surviving product lines. This inflates the reported unit costs of the remaining products, making them appear uncompetitive or unprofitable, which tempts management to close another line, triggering an overhead allocation death spiral . ┌─────────────────────────────────────────────────────────────┐

  • │ The Overhead Allocation Death Spiral Mechanism │
  • └─────────────────────────────────────────────────────────────┘
  • Segment shows net loss due to arbitrary overhead allocation
  • │
  • ▼
  • Management terminates the segment
  • │
  • ▼
  • Unavoidable corporate overhead persists unchanged in total cash
  • │
  • ▼
  • Overhead is reallocated across fewer surviving segments
  • │
  • ▼
  • Surviving segments show degraded margins and appear loss-making
  • │
  • ▼
  • Cycle repeats until entire enterprise collapses
  • The Segment Margin Rule

A product line or operating segment should only be dropped if its contribution margin is less than its avoidable fixed costs. In other words, a segment should be retained whenever it generates a positive Segment Margin ( S M > 0 SM > 0 SM > 0 ): Segment Margin = Segment Contribution Margin − Direct Avoidable Fixed Costs \text{Segment Margin} = \text{Segment Contribution Margin} - \text{Direct Avoidable Fixed Costs} Segment Margin = Segment Contribution Margin − Direct Avoidable Fixed Costs Net Financial Impact of Closure = Avoidable Fixed Costs Saved − Lost Segment Contribution − Complementary Spillover Contribution Lost \text{Net Financial Impact of Closure} = \text{Avoidable Fixed Costs Saved} - \text{Lost Segment Contribution} - \text{Complementary Spillover Contribution Lost} Net Financial Impact of Closure = Avoidable Fixed Costs Saved − Lost Segment Contribution − Complementary Spillover Contribution Lost

Corporate Application: Pacific Health Instruments Ltd

Pacific Health Instruments Ltd manufactures three diagnostic medical product lines: CardioScan, NeuroCheck, and DermaView. The management team is reviewing the annual segment income statement prepared under conventional full absorption costing:

Traditional Segment Performance Statement

  • Line Item CardioScan NeuroCheck DermaView Total Enterprise
  • Sales Revenue $3,000,000 $2,200,000 $1,400,000 $6,600,000
  • Less: Variable Manufacturing Costs ($1,500,000) ($1,100,000) ($840,000) ($3,440,000)
  • Less: Variable Selling & Distribution ($300,000) ($220,000) ($140,000) ($660,000)
  • Contribution Margin $1,200,000 $880,000 $420,000 $2,500,000
  • Less: Traceable Avoidable Fixed Costs ($550,000) ($410,000) ($270,000) ($1,230,000)
  • Segment Margin (Direct Controllable) $650,000 $470,000 $150,000 $1,270,000
  • Less: Apportioned Corporate Overheads ($450,000) ($330,000) ($240,000) ($1,020,000)
  • Reported Net Profit / (Loss) +$200,000 +$140,000 (-$90,000) +$250,000

The Chief Executive Officer proposed immediately discontinuing DermaView to eliminate its $90,000 reported loss, forecasting that company-wide net profit would increase from $250,000 to $340,000.

The Strategic Management Accounting Evaluation

The strategic management accountant investigated the operational dependencies and revealed three critical findings:

Corporate Overhead Persistence: The $240,000 of apportioned corporate overhead represents executive salaries, IT licenses, and legal retainers. None of these expenses will decrease if DermaView is discontinued. If DermaView is dropped, this $240,000 will be reallocated to CardioScan ($138,460) and NeuroCheck ($101,540).

Direct Segment Contribution: DermaView generates $420,000 of contribution margin and incurs only $270,000 of avoidable fixed costs. It generates a positive segment margin of +$150,000 toward covering corporate overheads.

Complementary Product Interdependence: Commercial hospitals bundle their diagnostic procurement contracts. Marketing intelligence indicates that 20% of CardioScan customers purchase CardioScan specifically because Pacific Health offers a unified software ecosystem with DermaView. Discontinuing DermaView will trigger a 15% cancellation rate in CardioScan sales (15% × $1,200,000 = $180,000 in lost CardioScan contribution margin).

Net Enterprise Profit Impact of Closing DermaView Avoidable Fixed Costs Saved = + $ 270 , 000 \text{Avoidable Fixed Costs Saved} = +\text{\textdollar}270,000 Avoidable Fixed Costs Saved = + $ 270 , 000 Lost DermaView Contribution Margin = − $ 420 , 000 \text{Lost DermaView Contribution Margin} = -\text{\textdollar}420,000 Lost DermaView Contribution Margin = − $ 420 , 000 Lost CardioScan Complementary Contribution = − $ 180 , 000 \text{Lost CardioScan Complementary Contribution} = -\text{\textdollar}180,000 Lost CardioScan Complementary Contribution = − $ 180 , 000 Net Enterprise Impact = $ 270 , 000 − $ 420 , 000 − $ 180 , 000 = − $ 330 , 000 \text{Net Enterprise Impact} = \text{\textdollar}270,000 - \text{\textdollar}420,000 - \text{\textdollar}180,000 = -\text{\textdollar}330,000 Net Enterprise Impact = $ 270 , 000 − $ 420 , 000 − $ 180 , 000 = − $ 330 , 000

Instead of increasing profit by $90,000, discontinuing DermaView would plunge total enterprise profit from $250,000 to a net loss of -$80,000 ($250,000 - $330,000). The board accepted the accountant's analysis and retained the product line.

Exam Traps to Avoid

Warning

Exam Trap 1 (The Full Cost Special Pricing Fallacy): When appraising a special pricing order during periods of excess capacity, never calculate the minimum price based on full absorption cost per unit. As long as regular sales are unaffected and capacity is idle, existing fixed overheads are irrelevant only to the extent that they remain unchanged; future committed costs differ from sunk past costs.

Note

Exam Trap 2 (Ignoring Cross-Elasticity / Complementary Goods): Exam questions frequently describe a loss-making product line that acts as a "loss leader" or gateway product. Dropping the product forfeits both its own segment margin and the high-margin accessory sales tied to it.

Loading diagram... The Overhead Allocation Death Spiral